73 related articles for article (PubMed ID: 18987658)
1. Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9).
Albano F; Anelli L; Zagaria A; Pannunzio A; Liso V; Rocchi M; Specchia G
Leukemia; 2009 Apr; 23(4):813-6. PubMed ID: 18987658
[No Abstract] [Full Text] [Related]
2. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
3. Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia.
Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Mancini M; Cuneo A; Pane F; Foà R; Manolelli F; Liso V; Rocchi M
Leukemia; 2003 Mar; 17(3):528-31. PubMed ID: 12646940
[TBL] [Abstract][Full Text] [Related]
4. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
5. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
6. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
[TBL] [Abstract][Full Text] [Related]
7. Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia.
Reid AG; Nacheva EP
Genes Chromosomes Cancer; 2005 Jun; 43(2):223-4; author reply 225. PubMed ID: 15751036
[No Abstract] [Full Text] [Related]
8. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
[TBL] [Abstract][Full Text] [Related]
9. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
[TBL] [Abstract][Full Text] [Related]
10. High incidence of derivative chromosome arm 9q deletions in Asian chronic myelogenous leukemia.
Tien SL; Rudduck-Sivaswaren C; Lim P; Lim E; Lie DK; Tan PH; Lee AS
Genes Chromosomes Cancer; 2005 Apr; 42(4):433-4. PubMed ID: 15645497
[No Abstract] [Full Text] [Related]
11. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
[TBL] [Abstract][Full Text] [Related]
12. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
[TBL] [Abstract][Full Text] [Related]
13. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients.
Storlazzi CT; Specchia G; Anelli L; Albano F; Pastore D; Zagaria A; Rocchi M; Liso V
Genes Chromosomes Cancer; 2002 Nov; 35(3):271-6. PubMed ID: 12353269
[TBL] [Abstract][Full Text] [Related]
14. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome 8 trisomy in 2 cases of negative ABL/BCR chronic myeloid leukemia ].
Vargas MT; Fernández-Novoa Mdel C; García-Creus MD; González J
Rev Med Chil; 2002 Apr; 130(4):460-2. PubMed ID: 12090113
[No Abstract] [Full Text] [Related]
16. Philadelphia chromosome-positive chronic myeloid leukemia with p190(BCR-ABL) rearrangement, overexpression of the EVI1 gene, and extreme thrombocytosis: a case report.
Balatzenko G; Guenova M; Stoimenov A; Jotov G; Toshkov S
Cancer Genet Cytogenet; 2008 Feb; 181(1):75-7. PubMed ID: 18262061
[No Abstract] [Full Text] [Related]
17. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
[TBL] [Abstract][Full Text] [Related]
18. Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia.
Douet-Guilbert N; Morel F; Quemener S; Maguer A; Le Bris MJ; Morice P; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2006 Oct; 170(2):89-92. PubMed ID: 17011977
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
[TBL] [Abstract][Full Text] [Related]
20. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
